Home » Topics » BioWorld Science

BioWorld Science
RSS

Y-Trap, Merck KGaA announce immuno-oncology collaboration

Sep. 20, 2019

Japanese approval for Evrenzo for anemia associated with chronic kidney disease in dialysis patients

Sep. 20, 2019

Xortx reports promising phase II data with TMX-049 in type 2 diabetic nephropathy

Sep. 20, 2019

Takeda Pharmaceutical identifies somatostatin SST4 receptor agonists

Sep. 20, 2019

Caveolin-1 deficiency links type 2 diabetes to sporadic AD

Sep. 20, 2019

Annapurna Bio discovers apelin receptor agonists

Sep. 20, 2019

Incyte presents new adenosine A2A and/or A2B receptor antagonists

Sep. 20, 2019

Dart NeuroScience divulges new OPRL1 antagonists

Sep. 20, 2019

U.S. investigators patent KRAS mutant inhibitors

Sep. 20, 2019

Phase Ib data on IMCY-0098 in young adults with recent-onset type 1 diabetes presented

Sep. 20, 2019

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...